[go: up one dir, main page]

PL432842A1 - LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE - Google Patents

LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE

Info

Publication number
PL432842A1
PL432842A1 PL432842A PL43284220A PL432842A1 PL 432842 A1 PL432842 A1 PL 432842A1 PL 432842 A PL432842 A PL 432842A PL 43284220 A PL43284220 A PL 43284220A PL 432842 A1 PL432842 A1 PL 432842A1
Authority
PL
Poland
Prior art keywords
lps
food
individual
inducing tolerance
mediated
Prior art date
Application number
PL432842A
Other languages
English (en)
Inventor
Ewa Kozłowska
Nadzieja DRELA
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Priority to PL432842A priority Critical patent/PL432842A1/pl
Priority to PCT/PL2021/050003 priority patent/WO2021162563A1/en
Publication of PL432842A1 publication Critical patent/PL432842A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Przedmiotem wynalazku jest LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe związane z alergiami pokarmowymi zależnymi od IgE, przy czym stosuje się LPS pochodzący z bakterii E. coli ze szczepu 0111:B4, który podaje się osobnikowi przed kontaktem z alergenem.
PL432842A 2020-02-10 2020-02-10 LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE PL432842A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL432842A PL432842A1 (pl) 2020-02-10 2020-02-10 LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE
PCT/PL2021/050003 WO2021162563A1 (en) 2020-02-10 2021-02-10 Lipopolysaccharides for treating food allergies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL432842A PL432842A1 (pl) 2020-02-10 2020-02-10 LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE

Publications (1)

Publication Number Publication Date
PL432842A1 true PL432842A1 (pl) 2021-08-16

Family

ID=75439422

Family Applications (1)

Application Number Title Priority Date Filing Date
PL432842A PL432842A1 (pl) 2020-02-10 2020-02-10 LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE

Country Status (2)

Country Link
PL (1) PL432842A1 (pl)
WO (1) WO2021162563A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000042994A2 (en) * 1999-01-21 2000-07-27 North Shore-Long Island Jewish Research Institute Inhibition of bacterial dissemination
DE10013539B4 (de) * 2000-03-20 2006-07-13 Pharma-Zentrale Gmbh Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen
DE10125179A1 (de) * 2001-05-23 2002-12-05 Laves Ralph Georg Verwendung von LPS zur Behandlung intestinaler Entzündungsprozesse
US8563523B2 (en) * 2007-09-07 2013-10-22 University Of Georgia Research Foundation, Inc. Synthetic lipid A derivative

Also Published As

Publication number Publication date
WO2021162563A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
MX393928B (es) Composiciones alergénicas mixtas y métodos de uso de las mismas.
MX387574B (es) Composición que comprende una mezcla de moléculas extraídas de chrysanthellum indicum, cynara scolymus y lycium barbarum y uso para que actúe en el metabolismo de carbohidratos y/o grasas.
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
PH12018500566B1 (en) Novel lactobacillus having various functions, and use thereof
AR109170A2 (es) Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente
BR112017003948A2 (pt) composição
CO2019011847A2 (es) Albúminas de guisante mejoradas, método para obtener las mismas y aplicaciones de las mismas
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
BR112019014397A2 (pt) Composições de neisseria meningitidis e métodos das mesmas
MA35195B1 (fr) Compositions lipidiques algales, leurs procédés de préparation et leurs utilisations
WO2004076481A3 (en) Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus
CL2013003298A1 (es) Uso de metotrexato porque sirve para preparar un medicamento, útil en el tratamiento de enfermedades que necesiten tratamiento con un producto terapéutico que produzca autoinmunidad, administrado en un sólo ciclo.
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
PL432842A1 (pl) LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE
Wau et al. Levels of Stress Related to Incidence of Gastritis in Adolescents
Chatain et al. Medicinal bioactivites and allergenic properties of pumpkin seeds: review upon a pediatric food anaphylaxis case report
DE60109180D1 (de) Parietaria judaica ns-ltp-antigenvarianten, entsprechende pharmazeutische zusammensetzungen und ihre verwendung
EP3612570A4 (en) POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
Inoue et al. A survey comparing the route of HIV transmission reported by patients to their physicians and the self-reported" actual route"
BR112018000102A2 (pt) composições e métodos para modular e/ou estimular respostas imunológicas em seres humanos e/ou animais
WO2009104184A3 (en) Extracts of sclerocarya birrea
Byambaa Nature-focal rickettsioses in Mongolia. Two decades of Russian-Mongolian scientific collaboration
Kim et al. A clinical study of bee venom acupuncture therapy on external epicondylitis
Jeon et al. A case of latex-fruit syndrome in a patient with latex anaphylaxis
Hajavi et al. Investigating Food Allergy Frequency Among Native Population and University Students in Gonabad